Biolex Inc., of Pittsboro, N.C., and OctoPlus Technologies BV, of Leiden, Netherlands, entered a collaboration for co-development of a controlled-release formulation of recombinant human alpha-interferon called Locteron.(Other News To Note)(Brief Article)

* Biolex Inc., of Pittsboro, N.C., and OctoPlus Technologies BV, of Leiden, Netherlands, entered a collaboration for co-development of a controlled-release formulation of recombinant human alpha-interferon called Locteron. The …